Brilinta and Clexane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Brilinta (ticagrelor) and Clexane (enoxaparin sodium). Common drug interactions include catheter site haematoma among females and brain death among males.

The phase IV clinical study analyzes what interactions people have when they take Brilinta and Clexane. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

On Jul, 14, 2026

37 people who take Brilinta and Clexane together, and have interactions are studied.

What are the common drug interactions of Brilinta and Clexane, by gender? *:

female:

Catheter site haematoma (blood clot at catheter site)
Haematoma (collection of blood outside the blood vessels)
Gastric haemorrhage (bleeding stomach)
Gastric ulcer (stomach ulcer)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Cardiogenic shock (inadequate circulation of blood)
Acute myocardial infarction (acute heart attack)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)

male:

Brain death
Acute myocardial infarction (acute heart attack)
Gastric haemorrhage (bleeding stomach)
Gout (uric acid crystals building up in the body)
Haemoglobin decreased
Myalgia (muscle pain)
Pulmonary oedema (fluid accumulation in the lungs)
Rectal haemorrhage (bleeding from anus)
Activities of daily living impaired
Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the common drug interactions of Brilinta and Clexane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Alanine aminotransferase increased
Thermal burn (burn by heat)

40-49:

n/a

50-59:

Brain death
Carotid artery occlusion (artery blockage)
Cerebellar haemorrhage (bleeding in cerebeller)
Cardiogenic shock (inadequate circulation of blood)
Activities of daily living impaired
Acute myocardial infarction (acute heart attack)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Cardiac failure acute
Coronary artery restenosis (recurrence of narrowing of artery)
Dizziness

60+:

Gastric haemorrhage (bleeding stomach)
Acute myocardial infarction (acute heart attack)
Cardiogenic shock (inadequate circulation of blood)
Cerebral haemorrhage (bleeding within the brain)
Gout (uric acid crystals building up in the body)
Haemoglobin decreased
Myalgia (muscle pain)
Rectal haemorrhage (bleeding from anus)
Brain compression
Coma (state of unconsciousness lasting more than six hours)

What are the existing conditions these people have? *

Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 14 people, 37.84%
Heart Attack: 8 people, 21.62%
Acute Myocardial Infarction (acute heart attack): 7 people, 18.92%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Brilinta and Clexane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously